Nuritas was founded by mathematician and bioinformatics expert Dr. Nora Khaldi in 2014.
Nuritas uses big data techniques to sieve through large amounts of data to discover peptides from food and food by-products which provide unique solutions for the maintenance of health and wellness. These benefits include: anti-inflammatory activity, antimicrobial activity, muscle recovery enhancement, anti-aging solutions, and the potential management of blood sugar levels for type 2 diabetics and other glucose transportation related areas.
Nuritas joined our second NDRC VentureLab cohort and during the acceleration programme, with the company expanding its team to include Emmet Browne, former regional president of Pfizer, as CEO.
Upon completing the accelerator programme at NDRC, Khaldi said: “NDRC helped bridge the gap between academia and industry. It was a great support and that’s what I needed in the first six months of jumping into entrepreneurship.”
High-profile Silicon Valley investor Ali Partovi, who previously invested in Facebook and Dropbox, was part of their €5m seed funding round completed in the first quarter of 2016.
The Dublin-based company has received numerous global awards such as the 2015 SVG Thrive Accelerator Award at the 'Forbes Reinventing America Summit' and has presented at cutting-edge events such as The Future Food-Tech Summit in New York in 2016.